Developing a model to diagnose and monitor dementia in Parkinson's disease using imaging and other measures

Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease

NIH-funded research University of Alabama at Birmingham · NIH-10889167

This study is looking for the best ways to spot dementia in people with Parkinson's disease by using special brain scans and other health information, so we can help diagnose it earlier and find better treatments for those who need them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-10889167 on NIH RePORTER

What this research studies

This research aims to identify the most effective biomarkers for diagnosing dementia in patients with Parkinson's disease by utilizing a combination of advanced imaging techniques and non-imaging data. The study will analyze neuroimaging measures such as diffusion-weighted MRI and resting-state functional MRI alongside demographic, clinical, genetic, and cerebrospinal fluid measures. By understanding the underlying mechanisms of dementia in Parkinson's disease, the research seeks to improve early diagnosis and patient management. This could lead to better prognostic tools and the identification of patients who may benefit from new treatments.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are at risk of developing dementia.

Not a fit: Patients who do not have Parkinson's disease or those who are not at risk of developing dementia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and earlier diagnoses of dementia in Parkinson's disease, improving patient outcomes and treatment options.

How similar studies have performed: Previous research has shown promise in using multimodal approaches to identify biomarkers for dementia, suggesting that this method could be effective.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.